Longterm Outcome of Liver Transplantation for Congenital Extrahepatic Portosystemic Shunt

Hajime Uchida, Seisuke Sakamoto, Mureo Kasahara, Hironori Kudo, Hideaki Okajima, Masaki Nio, Koji Umeshita, Hideki Ohdan, Hiroto Egawa, Shinji Uemoto, the Japanese Liver Transplantation Society – 28 May 2020 – Liver transplantation (LT) is often viewed as the last resort for the treatment of congenital extrahepatic portosystemic shunt (CEPS) due to advancement of imaging and interventional radiology techniques. However, some patients still require LT, and criteria for LT are yet to be determined.

The Sclerosing Cholangitis Outcomes in Pediatrics (SCOPE) Index: A Prognostic Tool for Children

Mark R. Deneau, Cara Mack, Emily R. Perito, Amanda Ricciuto, Pamela L. Valentino, Mansi Amin, Achiya Z. Amir, Madeleine Aumar, Marcus Auth, Annemarie Broderick, Matthew DiGuglielmo, Laura G. Draijer, Eleonora Druve Tavares Fagundes, Wael El‐Matary, Federica Ferrari, Katryn N. Furuya, Nitika Gupta, Jessica T. Hochberg, Matjaz Homan, Simon Horslen, Raffaele Iorio, M. Kyle Jensen, Maureen M. Jonas, Binita M. Kamath, Nanda Kerkar, Kyung Mo Kim, Kaija‐Leena Kolho, Bart G.P. Koot, Trevor J. Laborda, Christine K. Lee, Kathleen M.

Unraveling the Relationship Between Itching, Scratch Scales, and Biomarkers in Children With Alagille Syndrome

Binita M. Kamath, Cathie Spino, Richard McLain, John C. Magee, Emily M. Fredericks, Kenneth D. Setchell, Alexander Miethke, Jean P. Molleston, Cara L. Mack, Robert H. Squires, Estella M. Alonso, Karen F. Murray, Kathleen M. Loomes, M. Kyle Jensen, Saul J. Karpen, Philip Rosenthal, Danny Thomas, Ronald J. Sokol, Benjamin L. Shneider, for the Childhood Liver Disease Research Network (ChiLDReN) – 26 May 2020 – Pruritus is a debilitating symptom for patients with Alagille syndrome (ALGS).

Microsteatosis in Livers From Donation After Circulatory Death Donors Is Associated With Inferior Outcomes Following Liver Transplantation

Natalie M. Bath, Glen Leverson, David P. Al‐Adra, Anthony M. D’Alessandro, Joshua D. Mezrich, David P. Foley – 26 May 2020 – The acceptable threshold remains unknown for the percentage of macrosteatosis (MaS) and microsteatosis (MiS) to yield optimal outcomes after donation after circulatory death (DCD) liver transplantation (LT). The purpose of this analysis was to determine the impact of donor liver MaS and MiS on DCD LT outcomes.

Health Care Use and Costs Among Patients With Nonalcoholic Steatohepatitis With Advanced Fibrosis Using the Fibrosis‐4 Score

Stuart C. Gordon, Nandita Kachru, Emily Parker, Stephanie Korrer, A. Burak Ozbay, Robert J. Wong – 26 May 2020 – Limited evidence exists on the clinical and economic burden of advanced fibrosis in patients with nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) due to the invasiveness of liver biopsies for accurately staging liver disease. The fibrosis‐4 (FIB‐4) score allows for noninvasive assessment of liver fibrosis by using clinical and laboratory data alone.

Subscribe to